Rapid and quantitative testing at the next level of precision and speed, anywhere
The mission of ELIONOVA is to develop and commercialize an inovative diagnostic platform and in vitro diagnostic products for human and animal health. Our focus lies on rapid and highly accurate point of care diagnostics for on site use for human and veterinary medicine
Meet the Team
Dr. van Loon is a biochemist and molecular biologist with long experience in scientific research and product development. As head of Biotechnology of the F. Hoffmann-La Roche Vitamins and Fine Chemicals Division he was responsible for developing novel processes and products based on innovative science. His focus is on developing novel products based on innovative science.
He has been a full professor of Applied Optics at the EPFL, where he directed the Center for Laser Applications, the Institute of Applied Optics, and the Micro-Engineering department. His experience is essential for the optimization of the innovative laser technology required for our diagnostic device.
She is veterinarian and holds a doctorate degree in veterinary medicine from the University of Zurich and finished with a certificate of advanced studies at the Lucerne Business School. Since 2010 she has been associate professor for Veterinary Public Health at the University of Bern. At Prionics AG she drove the development of bovine tuberculosis diagnostics. Irene Schiller is also a co-founder of Malcisbo AG, where she acted as CMO.
He is an electrical engineer specialized in Biomedical Engineering. He worked as as an expert for medical systems at Sulzer Innotec and than then became CTO of the Medizintechnik Basler AG. Until recently he has been professor for Systems Engineering and Medical Electronics at the Interstaatliche Hochschule für Technik Buchs.
He he has been working at the ETH Zürich as full professor for Medial Image Analysis and Visualization. Between 2001 and 2013 he was Director of the Swiss National Centre of Competence in Research on Computer Aided and Image Guided Medical Interventions. Gabor Székely is co-founder and Board Member of the company Virtamed.
He is entrepreneur and investor having various mandates of Board of Directors and as Consultant. Jürg Stucki has a degree in Business Administration from the University of Applied Science Bern and collected comprehensive banking-, business- and finance expertise, including Wealth Management, Corporate Advisory and Investment Banking